We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBCP icon
1976
Independent Bank Corp
IBCP
$850M
$176K ﹤0.01%
11,863
DHIL
1977
DELISTED
Diamond Hill
DHIL
$176K ﹤0.01%
1,546
AGNT
1978
AGNT Inc
AGNT
$715M
$176K ﹤0.01%
20,614
SPPI
1979
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$176K ﹤0.01%
51,934
OCUL icon
1980
Ocular Therapeutix
OCUL
$2.25B
$175K ﹤0.01%
20,989
NX icon
1981
Quanex
NX
$1B
$175K ﹤0.01%
12,585
VHC icon
1982
VirnetX Holding Corp
VHC
$65.8M
$174K ﹤0.01%
1,342
BFS
1983
Saul Centers
BFS
$850M
$174K ﹤0.01%
5,405
MBWM icon
1984
Mercantile Bank Corp
MBWM
$1.06B
$174K ﹤0.01%
7,713
+1,667
+28% +$36.7K
DCO icon
1985
Ducommun
DCO
$3.04B
$174K ﹤0.01%
4,992
IBRX icon
1986
ImmunityBio
IBRX
$8.2B
$174K ﹤0.01%
+14,151
New +$79.9K
CSTL icon
1987
Castle Biosciences
CSTL
$960M
$174K ﹤0.01%
4,608
BWIN
1988
Baldwin Insurance Group
BWIN
$3B
$173K ﹤0.01%
10,025
+1,492
+17% +$18K
BDSI
1989
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$173K ﹤0.01%
39,589
MTW icon
1990
Manitowoc
MTW
$727M
$172K ﹤0.01%
15,849
FFG
1991
DELISTED
FBL Financial Group
FFG
$172K ﹤0.01%
4,790
XPRO icon
1992
Expro Ltd
XPRO
$2.07B
$172K ﹤0.01%
12,839
+4,254
+50% +$57.3K
VMD icon
1993
Viemed Healthcare
VMD
$353M
$172K ﹤0.01%
+17,890
New +$139K
IIIN icon
1994
Insteel Industries
IIIN
$635M
$172K ﹤0.01%
9,004
SRG
1995
Seritage Growth Properties
SRG
$131M
$171K ﹤0.01%
15,000
TEN
1996
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$171K ﹤0.01%
22,605
BFC icon
1997
Bank First Corp
BFC
$1.74B
$171K ﹤0.01%
2,663
CARS icon
1998
Cars.com
CARS
$648M
$170K ﹤0.01%
29,503
PRSU
1999
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
$170K ﹤0.01%
8,932
ALBO
2000
DELISTED
Albireo Pharma Inc
ALBO
$169K ﹤0.01%
6,398
+1,685
+36% +$39.7K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.